Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
Clinical trial NCT07164469 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07164469
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-28
- Primary completion
- 2031-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.